相关实验视频
Updated: Jun 4, 2025

08:46
An Improved Method for Rapid Intubation of the Trachea in Mice
Published on: February 22, 2016
25.1K
特里科斯塔丁A可以逆转火烧受伤的老鼠的罗库耐药性
Xiao Zhao1, Huijuan Wang1, Dian Xu1
1Department of Anesthesiology, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.
Burns : journal of the International Society for Burn Injuries
|December 27, 2024
概括
三素A (TSA),一种HDAC4抑制剂,在受烧伤的老鼠中逆转了对非脱极化肌肉松剂 (NDMRs) 的抵抗. 这表明TSA可以通过准HDAC4-myogenin通路来减轻NDMR耐药性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 麻醉学 麻醉学
背景情况:
- 烧伤伤害可能导致对非分极肌肉松剂 (NDMRs) 的耐药性.
- 希斯脱乙酶4 (HDAC4) 参与肌肉特异性基因调节.
- 了解NDMR耐药性的分子机制对于患者护理至关重要.
研究的目的:
- 调查HDAC4抑制剂三素A (TSA) 是否可以逆转由烧伤引起的NDMR耐药性.
- 阐明HDAC4-myogenin途径在这种耐药性中的作用.
主要方法:
- 建立了一种老鼠烧伤损伤模型.
- 使用TSA抑制HDAC4表达,并通过张力测试评估罗库的功效.
- 量化HDAC4和myogenin蛋白水平,使用西方污染和siRNA进行淘汰研究.
主要成果:
- 烧伤损伤增加了罗库的IC50,表明了耐药性,而TSA治疗逆转了这种情况.
- 在烧伤的组织中,TSA抵消了增加的HDAC4和肌原蛋白表达.
- 在受烧伤的老鼠中,HDAC4敲击降低了rocuronium IC50和蛋白质表达.
结论:
- HDAC4抑制剂TSA有效地减轻了烧伤后骨肌肉中非分极化肌肉松剂的阻力.
- HDAC4-myogenin通路是这种耐药性的关键媒介,也是潜在的治疗点.
相关概念视频
Depolarizing Blockers: Mechanism of Action
1.3K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.3K
Skeletal Muscle Relaxants: Therapeutic Uses
463
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
463
Depolarizing Blockers: Pharmocokinetics
305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305
Skeletal Muscle Relaxants: Adverse Effects
335
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
335
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
653
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
653
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
390
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
390

